Log in

NYSE:TFXTeleflex Stock Price, Forecast & News

$368.94
+4.96 (+1.36 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$363.97
Now: $368.94
$375.00
50-Day Range
$335.69
MA: $358.06
$376.58
52-Week Range
$221.27
Now: $368.94
$398.65
Volume260,176 shs
Average Volume257,604 shs
Market Capitalization$17.13 billion
P/E Ratio31.56
Dividend Yield0.37%
Beta1.01
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Read More
Teleflex logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.72 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$16.27 per share
Book Value$64.35 per share

Profitability

Net Income$461.47 million

Miscellaneous

Employees14,400
Market Cap$17.13 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

Teleflex (NYSE:TFX) Frequently Asked Questions

How has Teleflex's stock been impacted by COVID-19 (Coronavirus)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TFX stock has increased by 7.9% and is now trading at $368.94. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Teleflex?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Teleflex.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Teleflex.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings results on Thursday, April, 30th. The medical technology company reported $2.72 earnings per share for the quarter, topping analysts' consensus estimates of $2.30 by $0.42. The medical technology company had revenue of $630.60 million for the quarter, compared to analysts' expectations of $609.07 million. Teleflex had a net margin of 21.12% and a return on equity of 18.96%. Teleflex's quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter last year, the company earned $2.24 EPS. View Teleflex's earnings history.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Friday, May 15th will be paid a dividend of $0.34 per share on Monday, June 15th. This represents a $1.36 annualized dividend and a yield of 0.37%. The ex-dividend date is Thursday, May 14th. View Teleflex's dividend history.

What price target have analysts set for TFX?

10 equities research analysts have issued 1-year price objectives for Teleflex's shares. Their forecasts range from $275.00 to $431.00. On average, they anticipate Teleflex's share price to reach $383.40 in the next year. This suggests a possible upside of 3.9% from the stock's current price. View analysts' price targets for Teleflex.

Has Teleflex been receiving favorable news coverage?

Media stories about TFX stock have trended very negative this week, according to InfoTrie. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Teleflex earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned media coverage about the medical technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Teleflex.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Alibaba Group (BABA), NVIDIA (NVDA), AbbVie (ABBV), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Vertex Pharmaceuticals (VRTX), Visa (V), Adobe (ADBE), salesforce.com (CRM) and Pfizer (PFE).

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Pres, CEO & Director (Age 52)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 57)
  • Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 52)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, Chief Information Officer & VP

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $368.94.

How big of a company is Teleflex?

Teleflex has a market capitalization of $17.13 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.